Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

Share Price is delayed by 15 minutes
Get Live Data
12.60    -0.05 (-0.40%)
Bid:
12.60
Ask:
12.95
Spread: 0.35 (2.778%)
Market Cap: £42.85m
BVC Live PriceLast checked at - London Stock Exchange

Intraday Batm Advanced Share Chart

BATM secures first tier 1 customer for NFVTime

27 Aug 2020 07:00

RNS Number : 2625X
BATM Advanced Communications Ld
27 August 2020
Β 

LEI: 213800FLQUB9J289RU66

27 August 2020

Β 

BATM Advanced Communications Limited

("BATM" or "the Group")

Β 

BATM secures first tier 1 customer for NFVTime with multi-year licensing agreement

Leading international telecommunications provider adopts the Group's NFVTime solution for creating virtual networks

Β 

BATM (LSE: BVC; TASE: BVC), a leading provider of real-time technologies for networking solutions and medical laboratory systems, announces that it has a signed its first tier 1 customer for its NFVTime virtual networking solution. The customer, which is a leading telecommunications provider to multi-national enterprises and communication service providers globally and is headquartered in Asia, has entered a three-year licensing agreement, which follows the completion of a successful proof-of-concept.

Β 

The customer will use the NFVTime operating system, which was developed by the Group's wholly-owned Telco Systems subsidiary, to create virtual networks for customers and for operators that its services on a wholesale basis. The Group will receive a licence fee for a minimum of three years for each deployment of NFVTime, with a separate deployment required for each end customer (whether direct or via an operator) that adopts the solution.

Β 

The Group believes that the potential market for NFVTime is substantial. This new tier 1 customer alone serves enterprise and wholesale customers, including hundreds of operators, in more than 160 countries and 3,000 cities across North and South America, Asia, Europe, the Middle East and Africa. In addition, as a software solution, NFVTime can be deployed remotely, is extremely scalable and carries a significantly higher margin than the Group's traditional carrier Ethernet products.

Β 

Network function virtualisation ("NFV") enables network functions to be run in software, with a single piece of equipment, rather than requiring multiple pieces of physical hardware. This reduces the time, cost and carbon footprint of service deployment and management. NFV can also be a key element in leveraging the benefits offered by 5G and Internet of Things. The Group believes it is well-positioned to benefit from the expected demand for NFV as NFVTime is one of few solutions that can operate on both Arm-based and Intel-based architectures (with this new tier 1 customer intending to operate NFVTime on Intel's x86 processor architecture).

Β 

Dr Zvi Marom, Chief Executive Officer of BATM, said: "This is extremely significant for BATM as our first tier 1 customer for our NFVTime solution. This agreement represents the achievement of a fundamental milestone in the execution of our NFV strategy, and is something we have been working towards for several years. It follows a successful proof-of-concept, like what we recently announced with Vodafone and Arm as well as many others, and we are making good progress towards the potential contract stage with those as well. We believe this agreement and the NFV market will prove lucrative for BATM.

Β 

"The market for NFV is substantial as network carriers look towards the rollout of 5G. Equally, COVID-19 has clearly demonstrated the value of being able to deploy and manage network services remotely. We believe that we are well-placed to succeed in this market as one of few companies able to integrate with both Arm and Intel architectures as well as having built an eco-system of Virtual Network Functions around NFVTime over the last few years. This new agreement, combined with the recent successful completion of a proof-of-concept with Vodafone, gives us great confidence in the prospects for NFVTime and we look forward to reporting on our progress."

Β 

Β 

Enquiries:

Β 

Β 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Moti Nagar, Chief Financial Officer

Shore Capital

Mark Percy, Anita Ghanekar, James Thomas (Corporate Advisory)

Henry Willcocks (Corporate Broking)

+44 20 7408 4050Β 

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
CNTFLFSATVIRFII
Date   Source Headline
26th May 20267:00 amRNSBlock Listing Interim Review
21st Apr 20267:00 amRNSPublication of Annual Report
11th Mar 20267:00 amRNSFull Year Results
3rd Mar 202612:00 pmRNSHolding(s) in Company
10th Feb 20267:00 amRNSSale of Non-core Business
3rd Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSHolding(s) in Company
19th Jan 20267:00 amRNS-RBATM selected as FPT Israel cybersecurity partner
12th Jan 20267:00 amRNSHolding(s) in Company
12th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 202611:00 amRNSTransaction in own shares and Total Voting Rights
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:01 amRNSDirector Declaration
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
2nd Jan 20267:00 amRNSCompletion of Sale of Diagnostics Distributor
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
29th Dec 20257:00 amRNSAppointment of Chairman and Directorate Change
10th Dec 202512:00 pmRNSAGM Result, Directorate Change & AMS Sale Update
1st Dec 20257:00 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSBlock Listing Interim Review
17th Nov 20257:00 amRNSNew Carrier Ethernet Order
5th Nov 20257:00 amRNSNotice of AGM and Directorate Changes
6th Oct 20257:00 amRNSSale of Diagnostics Distributor
26th Sep 20257:00 amRNSDirectorate Change
18th Aug 20257:00 amRNSInterim Results
4th Aug 20257:00 amRNSTotal Voting Rights
24th Jul 20257:00 amRNSSale of Non-Core Businesses and Notice of Results
23rd Jun 20257:00 amRNSDirectorate Change
27th May 20257:00 amRNSBlock Listing Interim Review
12th May 20257:00 amRNSOrder for ultra-high speed encryption development
6th May 20257:00 amRNS-RBATM unveils new brand identity
8th Apr 202511:00 amRNSAnnual Report Publication and AGM Update Statement
27th Mar 20257:00 amRNSNew strategic customer for Edgility in Brazil
17th Mar 20257:00 amRNSFull Year Results
5th Mar 20257:00 amRNSUpdate on Strategy and Trading
24th Feb 20257:00 amRNSHolding(s) in Company
16th Jan 20257:00 amRNSADOR appoints Nadhim Zahawi to lead Advisory Board
19th Dec 20243:30 pmRNSResult of AGM and Director Appointment
19th Dec 20247:00 amRNSNew Tier 1 Customer for Edgility in Mexico
11th Dec 20247:00 amRNSNATlab commences pre-clinical validation
3rd Dec 20247:00 amRNSBlock Listing Interim Review
2nd Dec 20247:00 amRNSBATM receives orders of $2.4m for Edgility
25th Nov 20247:00 amRNSBlock listing Interim Review
14th Nov 202411:00 amRNSNotice of AGM and Proposed Director Appointment
4th Nov 20247:00 amRNSTotal Voting Rights
19th Aug 20247:00 amRNSInterim Results
10th Jul 20247:00 amRNSAmazon Web Services partnership for Edgility
2nd Jul 20247:00 amRNSCommercial markets cybersecurity partnership
3rd Jun 20247:00 amRNSBlock Listing Interim Review
28th May 20247:00 amRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.